| Primary |
| Factor Viii Deficiency |
36.7% |
| Drug Use For Unknown Indication |
11.7% |
| Prophylaxis |
7.8% |
| Haemophilia |
7.0% |
| Postpartum Haemorrhage |
4.7% |
| Haemorrhage |
3.9% |
| Acquired Haemophilia |
3.1% |
| Acute Coronary Syndrome |
3.1% |
| Analgesia |
3.1% |
| Procoagulant Therapy |
3.1% |
| Diabetes Mellitus |
2.3% |
| Hypertension |
2.3% |
| Immune System Disorder |
2.3% |
| Factor Viii Inhibition |
1.6% |
| Haemarthrosis |
1.6% |
| Haemorrhage Prophylaxis |
1.6% |
| Tooth Extraction |
1.6% |
| Angiogram |
0.8% |
| Haemophilic Arthropathy |
0.8% |
| Pilonidal Sinus Repair |
0.8% |
|
| Haematoma |
13.6% |
| Haemorrhage |
13.6% |
| Factor Viii Inhibition |
10.2% |
| Haemorrhagic Diathesis |
8.5% |
| Intracranial Haematoma |
8.5% |
| Pneumonia |
6.8% |
| Human Anti-mouse Antibody Positive |
5.1% |
| Injection Site Urticaria |
5.1% |
| Acute Myocardial Infarction |
3.4% |
| Hepatic Neoplasm Malignant |
3.4% |
| Pain |
3.4% |
| Post Procedural Haemorrhage |
3.4% |
| Venous Thrombosis Limb |
3.4% |
| Anti Factor Viii Antibody Positive |
1.7% |
| Arthralgia |
1.7% |
| Cardiac Operation |
1.7% |
| Chest Pain |
1.7% |
| Drug Tolerance |
1.7% |
| Haemarthrosis |
1.7% |
| Haemophilia |
1.7% |
|
| Secondary |
| Factor Viii Deficiency |
37.6% |
| Prophylaxis |
11.3% |
| Immune System Disorder |
10.7% |
| Drug Use For Unknown Indication |
6.9% |
| Factor Viii Inhibition |
6.6% |
| Diabetes Mellitus |
4.9% |
| Haemophilia |
4.9% |
| Haemorrhage |
2.8% |
| Haemostasis |
2.0% |
| Immune Tolerance Induction |
2.0% |
| Postpartum Haemorrhage |
1.5% |
| Haemarthrosis |
1.3% |
| Surgery |
1.3% |
| Wound Infection |
1.3% |
| Acquired Haemophilia |
1.0% |
| Acute Coronary Syndrome |
1.0% |
| Hepatitis C |
1.0% |
| Hypertension |
0.8% |
| Haemorrhage Prophylaxis |
0.5% |
| Tooth Extraction |
0.5% |
|
| Injection Site Urticaria |
13.2% |
| Factor Viii Inhibition |
12.7% |
| Haematoma |
12.7% |
| Venous Thrombosis Limb |
12.7% |
| Human Anti-mouse Antibody Positive |
10.7% |
| Haemorrhage |
10.2% |
| Venous Thrombosis |
7.8% |
| Haemorrhage Subcutaneous |
7.3% |
| Intracranial Haematoma |
4.4% |
| Cardiac Operation |
2.4% |
| Arthralgia |
1.0% |
| Post Procedural Haemorrhage |
1.0% |
| Haemarthrosis |
0.5% |
| Haemorrhagic Diathesis |
0.5% |
| Malaise |
0.5% |
| Product Quality Issue |
0.5% |
| Respiratory Failure |
0.5% |
| Sudden Death |
0.5% |
| Unresponsive To Stimuli |
0.5% |
| Urticaria |
0.5% |
|
| Concomitant |
| Hiv Infection |
52.0% |
| Hepatitis C |
11.5% |
| Product Used For Unknown Indication |
6.9% |
| Haemophilia |
6.7% |
| Factor Viii Deficiency |
3.4% |
| Gastritis |
3.4% |
| Drug Use For Unknown Indication |
3.2% |
| Chronic Hepatitis C |
2.5% |
| Coagulopathy |
1.6% |
| Acquired Immunodeficiency Syndrome |
1.4% |
| Haemarthrosis |
1.1% |
| Pain |
1.1% |
| Osteoporosis |
0.9% |
| Arthralgia |
0.7% |
| Hepatic Cirrhosis |
0.7% |
| Infection Prophylaxis |
0.7% |
| Pneumocystis Jiroveci Pneumonia |
0.7% |
| Bronchopulmonary Aspergillosis |
0.5% |
| Diarrhoea |
0.5% |
| Hypertension |
0.5% |
|
| Haemorrhage |
16.1% |
| Liver Function Test Abnormal |
16.1% |
| Hepatic Cirrhosis |
11.3% |
| Arthritis Bacterial |
8.1% |
| Pancytopenia |
6.5% |
| Renal Impairment |
4.8% |
| Renal Tubular Disorder |
4.8% |
| Urinary Sediment Abnormal |
4.8% |
| Death |
3.2% |
| Drug Ineffective |
3.2% |
| Gastrointestinal Haemorrhage |
3.2% |
| Haemarthrosis |
3.2% |
| Osteonecrosis |
3.2% |
| Anastomotic Haemorrhage |
1.6% |
| Factor Viii Inhibition |
1.6% |
| Hyperthermia |
1.6% |
| Primary Hypothyroidism |
1.6% |
| Sepsis |
1.6% |
| Shock Haemorrhagic |
1.6% |
| Small Intestine Carcinoma |
1.6% |
|
